Showing results (71-80 of 158) with videos related to
Sort By:
Pageof 16
Journal of Clinical Immunology|January 29, 2015
Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantationDivya Punwani, Haopeng Wang, Alice Y Chan, et al.BMC Medical Genetics|July 4, 2007
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type IbLilia L Bi, George Pan, T Prescott Atkinson, et al.Blood|April 3, 2010
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndromeKennichi C Dowdell, Julie E Niemela, Susan Price, et al.The Journal of Experimental Medicine|January 20, 2016
A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70Alice Y Chan, Divya Punwani, Theresa A Kadlecek, et al.Frontiers in Immunology|March 3, 2025
Disruption of the moonlighting function of CTF18 in a patient with T-lymphopeniaRobert Sertori, Billy Truong, Manoj K Singh, et al.Journal of Clinical Immunology|January 10, 2014
Bone density and fractures in autosomal dominant hyper IgE syndromeKathryn J Sowerwine, Pamela A Shaw, Wenjuan Gu, et al.American Journal of Hematology|January 25, 2006
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS)V Koneti Rao, Jorge A Carrasquillo, Janet K Dale, et al.The Journal of Experimental Medicine|July 16, 2008
Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylationGuillaume Vogt, Jacinta Bustamante, Ariane Chapgier, et al.American Journal of Hematology|October 1, 2024
C-CAR066, a novel fully human anti-CD20 CAR-T therapy for relapsed or refractory large B-cell lymphoma after failure of anti-CD19 CAR-T therapy: A phase I clinical studyPing Li, Wei Liu, Lili Zhou, et al.Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
NRAS mutation causes a human autoimmune lymphoproliferative syndromeJoão B Oliveira, Nicolas Bidère, Julie E Niemela, et al.Pageof 16